Alison Culpan


Alison Culpan is the Director of ABPI Scotland and is responsible for leading government affairs activity for the regional office.

Alison has worked in a number of capacities in the pharmaceutical industry in the UK including sales and marketing, project management, communication and external affairs. She has also gained global experience through her roles in GSK as the Director for Global Issues working with WHO, IFPMA and as Government Affairs Director for China.

Alison sits on the CBI Scotland Council and the Court of Strathclyde University

Session title

Ensuring access to new medicines across Scotland

Session synopsis

In 2016, the Review of Access to New Medicines was published and laid out a range of reccomendations for increasing the access patients in Scotland had to new medicines. The Scottish Medicines Consortium and Scottish Government have led significant progress in increasing access to medcine, however, our evolving understanding of cancer as a disease is leading to newer, more personalised treatments such as precision medicines and immunotherapies, but also adding complexity and cost. This session will ask what more can be done to allow as many patients in Scotland to access new medicines whilst maintaining cost-effectiveness of this access for NHS Scotland.